TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02480010

A Study of Pertuzumab in Participants With Prostate Cancer

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“The study was terminated at the time of interim analysis since none of the participants showed a PSA response.”

The sponsor’s own words in the registry.

Life of this trial

2004200620082010201220142016Started2003-09Stopped2005-09Registered2015-06-05Results posted2015-09-18

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Hoffmann-La Roche
Sponsor type
Industry
Conditions
Prostate Cancer
Interventions
Pertuzumab
Participants
68
Sites
11
Countries
France, Germany, Italy, Netherlands, Spain, United Kingdom

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.